Biotech Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation May 19, 2025
Biotech ArkBio Announces Positive Phase II Results of AK3280 for Treatment of Idiopathic Pulmonary Fibrosis (IPF) May 16, 2025
Biotech Tsingke Showcases at AACR 2025 — Advancing Global Cancer Research with Integrated Synthesis Solutions May 15, 2025
Biotech Kaerus Bioscience’s lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS) May 14, 2025
Biotech Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology May 13, 2025
Biotech Alphyn Doses First Patients in CLEAR-AD1 Global Phase 2b Clinical Trial Program for Atopic Dermatitis May 12, 2025
Biotech Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025 May 11, 2025
Biotech Anivive’s Dr. Edward Robb Presents Innovative Valley Fever Vaccine Research at World Vaccine Congress 2025 May 10, 2025